Marc Brumagne is a strategic advisor at Expon Capital.
With over two decades of experience in the biotechnology and pharmaceutical sectors, Marc currently serves as Senior Director of Global Commercial Operations for HIV at Gilead Sciences. In this role, he oversees global commercial strategies and operations, contributing to the advancement of HIV treatments worldwide.
Marc is actively involved in shaping the future of pharmaceutical commercialization. He has participated in panels discussing global commercialization strategies and the integration of artificial intelligence in pharma, sharing insights on innovative approaches to market access and customer engagement.
Beyond his corporate responsibilities, Marc is a member of the Digital Pharma Circle, a network of decision-makers in the pharma digital health space, fostering discussions that generate meaningful insights and drive innovation.
Marc’s extensive experience and commitment to innovation continue to influence the evolution of digital health solutions and global commercialization strategies in the pharmaceutical industry.